PCK2 and Alport syndrome: In contrast, the KO mice exhibited a significantly increased level of PEPCK expression at 7-week-old compared to 4-week-old (p = 0.024), which might indicate that the KO mice might have possessed an impaired PEPCK action and the level of gluconeogenesis might have changed with the disease progression in Alport syndrome.